Grow Your Client Base with a Targeted TSEG Campaign

EzriCare Artificial Tears have become the focus of widespread litigation due to the eye drops’ alleged links to serious health risks. These over-the-counter drops, which many people used to treat dry eyes, were recalled after contamination with a dangerous, drug-resistant bacteria called Pseudomonas aeruginosa. This contamination has reportedly led to severe infections, vision loss, and even deaths.

The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) identified the issue in early 2023, prompting a recall of EzriCare products. The bacterial contamination is linked to multiple manufacturing failures, including inadequate microbial testing and unsafe packaging practices. The bacteria, which thrives in contaminated water and soil, allegedly caused infections in over 80 patients by mid-2023, with numerous lawsuits following soon after.

With the number of EzriCare Eye Drops lawsuits growing, competition to secure clients is intense. Law firms handling these cases need effective EzriCare Eye Drops Mass Tort Marketing Campaigns to reach affected individuals. A strong digital marketing campaign connects your firm with claimants unaware of their legal options. TSEG helps your firm reach the right audience quickly and efficiently through expert marketing strategies. That way, you can focus on what you do best—representing your clients.

The Impact of the Contaminated Eye Drops

EzriCare Artificial Tears were designed to provide relief for dry eyes by moisturizing and soothing irritation resulting from dry eye disease (DED). Dry eye disease occurs when the eyes don’t produce enough tears or when the quality of the tears is poor. EzriCare’s formula, which included ingredients like carboxymethylcellulose sodium, was supposed to hydrate the eyes, reduce irritation, and improve overall comfort by forming a protective barrier over the eye’s surface.

Unfortunately, contamination in EzriCare’s eye drops reportedly caused severe harm to many users. Patients who relied on these eye drops developed infections from the drug-resistant Pseudomonas aeruginosa bacteria, which can cause severe health complications. Many users experienced painful eye infections, vision loss, and, in the most extreme cases, even death. The CDC linked these contaminated eye drops to over 80 confirmed infections by mid-2023.

This bacteria is especially dangerous because it is resistant to common antibiotics, so infections are difficult to treat. Some patients required corrective eye surgeries, while others suffered permanent vision loss or even required eye removal surgery. In certain cases, the infections spread beyond the eyes, causing life-threatening conditions such as sepsis and organ failure.

Recent Developments in EzriCare Litigation

EzriCare litigation continues to grow, with new plaintiffs filing claims against the manufacturers and distributors of the contaminated eye drops. The number of cases has increased as more people come forward reporting severe infections and complications linked to Pseudomonas aeruginosa. While no trials have started and no settlements have been reached, legal actions remain active, and more cases are expected to be filed.

In addition, plaintiffs continue to file class action lawsuits, including those seeking refunds for purchasing the contaminated products. Courts have not yet consolidated cases into multidistrict litigation (MDL), which could streamline the legal process, but the possibility remains as more lawsuits are filed.

These lawsuits involve a range of defendants, including Global Pharma Healthcare, the manufacturer of EzriCare, and various distributors and retailers like Amazon and Walmart that sold the drops. The plaintiffs argue that these parties failed to warn consumers about the risks associated with the contaminated products.

In early 2024, a federal court dismissed Amazon from a lawsuit, citing insufficient ties to the state. However, other defendants, such as EzriCare and Global Pharma Healthcare, still face claims. As the litigation progresses, law firms across the country continue to join the effort to represent victims of EzriCare’s harmful products and fight for justice on their behalf.

EzriCare Lawsuit Updates 2026

February 2026

There have been no major updates in the EzriCare and Delsam Pharma Artificial Tears litigation, but lawsuits are ongoing on behalf of plaintiffs who allege they developed severe infections and complications from the use of contaminated EzriCare Eye Drops and Delsam Pharma’s Artificial Tears eye drops.

No jury trials have been scheduled, and the suits have yet to be consolidated into multidistrict litigation.

January 2026

While there continue to be reports of individual lawsuits being filed alleging harmful effects of EzriCare and Delsam Pharma Artificial Tears, the cases have yet to be consolidated into multidistrict litigation.

There have been no reported global settlements, and no jury trials have been scheduled in these cases. The lawsuits focus on links between EzriCare eye drops and an outbreak of a bacterial infection that has led to permanent vision loss, surgical eyeball removal, and death.

December 2025

As of December 2025, individual lawsuits against EzriCare and Delsam Pharma Artificial Tears had yet to be consolidated into multidistrict litigation.

Plaintiffs have continued to file lawsuits claiming they contracted severe bacterial infections by using the company’s artificial tears, but no settlements have been disclosed, and no jury trials have been scheduled to date.

November 2025

No new developments were disclosed over the past month in the EzriCare and Delsam Pharma Artificial Tears litigation. While multiple individual lawsuits have been filed, they have yet to be consolidated into multi-district litigation.

It was reported that most law firms are no longer accepting new cases over the allegations which link bacterial contamination of eyedrops to a number of serious injuries, including vision problems, eye surgery, blindness and even death.

October 2025

Individual lawsuits continue to move forward in the EzriCare and Delsam Pharma Artificial Tears litigation, but they are proceeding separately and have yet to be consolidated into multidistrict litigation.

No settlements have been announced and no jury trials have been scheduled in the litigation, which involves allegations that contaminated eye drops manufactured by Global Pharma Healthcare caused severe bacterial infections, resulting in vision loss, surgical eye removal, and other injuries.

September 2025

No significant updates have been announced in the EzriCare and Delsam Pharma Artificial Tears litigation. While lawsuits continue to be filed by plaintiffs who allege serious injuries from the Artificial Tears, these cases had yet to be consolidated into multidistrict litigation as of September.

To date there have been no approved settlements and no jury trials have been scheduled. The lawsuits allege that contaminated EzriCare artificial tears led to severe bacterial infections.

August 2025

There have been no significant updates in the ongoing EzriCare and Delsam Pharma Artificial Tears litigation, in which lawsuits have been filed against EzriCare and its distributor, Global Pharma Healthcare.

Lawyers continue to accept new cases from those who used EzriCare Artificial Tears or Delsam Artificial Tears and subsequently experienced vision loss, eye infection, or other injuries as a result of bacterial contamination.

July 2025

While plaintiffs are filing personal injury claims in various states in the EzriCare and Delsam Pharma Artificial Tears case, the lawsuits continue to proceed separately and not as part of multidistrict litigation.

So far, there have been no approved settlements, and no jury trials have been scheduled. There have been reports of settlement negotiations involving plaintiffs who allege that contaminated eye drops sold by EzriCare and Delsam Pharma resulted in serious injuries and adverse events, including permanent vision damage, vision loss, and infections.

June 2025

While no major updates have been announced in this matter, lawsuits continue to be filed by people injured by EzriCare and Delsam Pharma’s Artificial Tears. The contaminated eyedrops have been linked to a number of serious injuries.

Over 100 cases of vision loss and severe infections have been blamed on the products, but the lawsuits have yet to be consolidated into multidistrict litigation and remain in the pretrial stages as plaintiffs continue to gather their evidence.

May 2025

More lawsuits are being filed in the EzriCare and Delsam Pharma Artificial Tears case, alleging that eye drops have been linked to an outbreak of bacterial infections.

While no major updates have been announced and no jury trials have been scheduled, lawyers believe there may be potential settlement negotiations that could lead to the end of this litigation.

The cases have not yet been consolidated into multidistrict litigation.

April 2025

There have been no major updates in the EzriCare and Delsam Pharma Artificial Tears litigation, but plaintiffs continue to file new lawsuits. The suits have yet to be consolidated into multidistrict litigation.

While no approved settlements or jury trials have been scheduled, lawyers familiar with the case say there are potential settlement talks in these cases.

March 2025

As of March, Ezricare and Delsam Pharma Aritificial Tears has not yet consolidated into a formal Ezricare multi-district litigation (MDL). While multiple lawsuits are active in districts throughout the U.S., the cases continue to proceed separately.

There have been no significant updates or news released around the litigation at this time.

February 2025

A new class action lawsuit has been filed in New Jersey against Global Pharma, Walgreens, and other entities for allegedly distributing contaminated EzriCare Artificial Tears. The lead plaintiff claims the defective eye drops led to severe infections.

No other major updates or news around the lawsuit have been released at this time.

January 2025

No major updates in the pending EzriCare litigation have been announced thus far this month.

In related news, however, Alcon Laboratories has issued a nationwide recall of its Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go due to potential contamination risks. While no adverse events have been reported, the company warns the product could pose serious health risks. Consumers are advised to stop use immediately.

December 2024

No major news or updates regarding the EzriCare MDL were announced in December.

Consumers may refer to the official recall notice released by Global Pharma Ltd. for its EzriCare Aritificial Tears. The communication lists a number of adverse health outcomes the FDA and CDC warns may be linked to the product, including “serious injury, blindness, and possible death due to a rate, serious bacterial infection.”

November 2024

While additional plaintiffs may be coming forward, no significant updates in the ongoing EzriCare MDL (multi-district litigation) have been reported.

October 2024

At this time, no news or updates in the ongoing EzriCare litigation have been released to the public, even as plaintiffs may be coming forward or more companies may be held to account in the coming future.

Why Choose TSEG to Generate Mass Tort Leads for Your Firm?

When choosing a partner to generate mass tort leads for your law firm, you need a team with the experience, tools, and strategies to deliver results. TSEG offers everything you need to run effective mass tort marketing campaigns for cases like the EzriCare eye drops litigation. We focus on mass torts, understand legal implications, and drive claimants to your law firm.

When you partner with us, we develop custom marketing campaigns that focus on attracting the right clients for your firm. Whether you’re looking to target individuals affected by contaminated eye drops or other mass tort cases, we design campaigns that speak directly to their needs. Using a combination of search engine optimization (SEO), pay-per-click (PPC) advertising, and social media strategies, we make sure your firm appears where potential clients are searching for legal help.

At TSEG, we also use data-driven insights to continuously optimize your campaign’s performance. We analyze traffic, engagement, and conversion rates to fine-tune your marketing efforts and ensure you get the highest return for your marketing dollar. This means you can focus on your legal work while we handle the heavy lifting of lead generation.

Our team also understands the importance of compliance. In mass tort marketing, it’s essential to follow ethical standards and advertising regulations. We work hard to ensure all your marketing materials meet the relevant legal requirements so your firm remains compliant while attracting new clients.

Partnering with TSEG means getting a marketing team dedicated to growing your client base through effective, targeted campaigns. With our experience, legal knowledge, and proven strategies, we can help your firm stand out in a crowded marketplace and secure leads for mass tort cases like EzriCare.

Partner with TSEG for Your EzriCare Mass Tort Marketing

Serious about taking on EzriCare mass tort cases? TSEG is your partner for cutting-edge digital marketing that delivers high-quality leads. Our campaigns are built for law firms like yours—ready to make a difference and grow. Let’s win together. Reach out online or call us at (512) 394-7234 today to get your custom strategy started.

FREQUENTLY ASKED QUESTIONS

What is a multi-channel approach in mass tort marketing?

A multi-channel approach in mass tort marketing involves deploying campaigns across various platforms such as digital, social media, and traditional media to ensure comprehensive market coverage and maximum engagement. This method leverages different channels to meet potential clients where they are most likely to be receptive to your messaging.

How does TSEG use data in mass tort marketing?

What is the role of SEO in mass tort marketing?

How does TSEG ensure ethical marketing practices?

What services does TSEG offer for mass tort campaigns?

Request a custom quote

Fill out a form below and we will have someone connect with you right away. You may also start a live chat or proceed to schedule an hour long consultation that fits your schedule.

EzriCare Eye Drops Mass Tort Marketing Campaigns for Lawyers

REQUEST A FREE CONSULTATION